JPMorgan Claverhouse (LON:JCH) Sets New 52-Week High - Time to Buy?

Key Points

• JPMorgan Claverhouse reached a new 52-week high during trading, hitting GBX 808.11 ($10.92) before closing at GBX 804 ($10.86).
• The investment trust has a market cap of £446.94 million and a PE ratio of 7.74, indicating relatively strong valuation metrics.
• JPMorgan Claverhouse reported an earnings per share of GBX 18.96 for the last quarter, with a net margin of 92.61% and a return on equity of 14.30%.

JPMorgan Claverhouse (LON:JCH - Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 808.11 ($10.92) and last traded at GBX 804 ($10.86), with a volume of 84051 shares trading hands. The stock had previously closed at GBX 801 ($10.82).

JPMorgan Claverhouse Trading Up 0.4%

The firm has a market cap of £446.94 million, a PE ratio of 7.74 and a beta of 0.83. The company's fifty day moving average price is GBX 789.26 and its two-hundred day moving average price is GBX 756.95. The company has a quick ratio of 67.67, a current ratio of 0.71 and a debt-to-equity ratio of 11.85.

JPMorgan Claverhouse (LON:JCH - Get Free Report) last issued its earnings results on Thursday, August 14th. The investment trust reported GBX 18.96 earnings per share for the quarter. JPMorgan Claverhouse had a net margin of 92.61% and a return on equity of 14.30%.

About JPMorgan Claverhouse

Great British dividends The JPMorgan Claverhouse Investment Trust has been helping investors tap directly into the long-term growth potential of UK large cap stocks since 1963. The trust focuses on attractively valued, high quality stocks with the ability to generate consistent and growing dividends. Key points Expertise • Managed by an investment team with long-standing UK equity experience, backed by the extensive resources of J.P.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.